EGFR and acute myeloid leukemia: KEGG analysis revealed notably enriched pathways, including PI3K-AKT, MAPK, Ras, JAK-STAT, acute myeloid leukemia, EGFR tyrosine kinase inhibitors, and endocrine resistance (Supplementary Figure S2B).